Clinical trial
The Evaluation of Safety and Effectiveness of Intraarticular Administration of Autologous Stromal-Vascular Fraction of Adipose Tissue Cells for Treatment of Knee Joint Arthrosis
NCT04050111 is registered in ClinicalTrials.gov with Swiss Medica XXI Century S.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Evaluation of Safety and Effectiveness of Intraarticular Administration of Autologous Stromal-Vascular Fraction of Adipose Tissue Cells for Treatment of Knee Joint Arthrosis
- Lead sponsor
- Swiss Medica XXI Century S.A.
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- August 21, 2019
- Completion date
- August 22, 2021
- Enrollment
- 30 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
knee osteoarthritis